Table 1.
Overview of the classic psychedelic drugs.
Hallucinogen | Chemical class | Potential therapeutic applications | Therapeutic mechanisms |
---|---|---|---|
Ayahuasca/DMT | Tryptamine | Anxiety,10 depression,11 substance misuse12 | Increased BDNF,11 neurogenesis/plasticity,13 MAO Inhibition11 |
LSD | Tryptamine | Anxiety,14 depression,15 substance misuse16 | Amygdala and DMN alterations,17 mystical experience18 |
Mescaline | Phenethylamine | No clinical applications studied to-date | |
Psilocybin | Tryptamine | Anxiety,19 depression,20 OCD,21 substance misuse22 | Amygdala and DMN alterations,23 mystical experience,22 neurogenesis/plasticity24 |
BDNF, brain-derived neurotrophic factor; DMT, N,N-dimethyltryptamine; LSD, lysergic acid diethylamide; MAO, monoamine oxidase inhibitor; OCD, obsessive-compulsive disorder.